Keyphrases
Pulmonary Hypertension
100%
Lipid Ratios
100%
Control Subjects
36%
Validation Cohort
27%
Training Population
27%
Fatty Acids
27%
Human Pulmonary Artery
18%
Idiopathic Pulmonary Arterial Hypertension
18%
Healthy Controls
18%
Lung
18%
Machine Learning
18%
Altered Expression
9%
Poor Prognostic
9%
Diagnostic Potential
9%
Patient Identification
9%
Health Threat
9%
Mortality Risk
9%
Acute Effects
9%
Human Pulmonary Artery Smooth muscle Cells
9%
Lipid Modification
9%
Clinical Markers
9%
Pulmonary Artery
9%
Hazard Ratio
9%
Patient Management
9%
Lipid Homeostasis
9%
Abnormal Proliferation
9%
Clinical Score
9%
Lipid Metabolism
9%
Pathological Changes
9%
Prognostic Information
9%
Diagnostic Information
9%
Area under the Curve
9%
Diagnostic Accuracy
9%
Metabolomics Approach
9%
Learning Results
9%
Barrier Dysfunction
9%
In Vitro Study
9%
Histologic
9%
Machine Learning Analysis
9%
Lipid Accumulation
9%
Liquid Chromatography-high Resolution Mass Spectrometry (LC-HRMS)
9%
External Validation
9%
Gene Expression Analysis
9%
Endothelial Cells
9%
Biochemistry, Genetics and Molecular Biology
Lipid
100%
Metabolite
66%
Lipid Metabolism
33%
Gene Expression Profiling
33%
Lipid Storage
33%
Resolution (Mass Spectrometry)
33%
Lipid Homeostasis
33%
In Vitro Study
33%
Medicine and Dentistry
Pulmonary Hypertension
100%
Pulmonary Artery
30%
Fatty Acid
23%
Biological Marker
15%
Metabolite
15%
Lung
15%
Smooth Muscle Cell
7%
Hazard Ratio
7%
Mass Spectrum
7%
Lipid Storage
7%
Lipid Homeostasis
7%
Endothelial Cell
7%
Diagnostic Accuracy
7%
Lipid Metabolism
7%
Gene Expression Profiling
7%
In Vitro
7%
